Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Di'er Pharmaceutical is a specialized pharmaceutical manufacturer based in Quzhou, China, with a core focus on Vitamin D series products and their synthetic derivatives. The company is a prominent global supplier of Active Pharmaceutical Ingredients (APIs) and finished dosages, including Alfacalcidol, Calcitriol, and Paricalcitol. Their expertise lies in high-potency API synthesis and GMP-compliant manufacturing, supporting treatments for metabolic bone diseases, secondary hyperparathyroidism, and dermatology. In addition to its Vitamin D portfolio, the company produces cardiovascular and anti-tumor medications. Zhejiang Di'er Pharmaceutical serves a broad international client base, maintaining rigorous quality standards to meet global regulatory requirements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Di'er Pharmaceutical.